Note 11 - Stock-based Compensation

6 Months Ended

Dec. 31, 2024

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

(11) Stock-Based Compensation

We have granted equity incentives to employees and directors in the form of stock options and restricted stock awards. The total stock-based compensation expense for all equity incentives was $261 thousand and $473 thousand for the three months ended December 31, 2024, and December 31, 2023, respectively. The total stock-based compensation expense for all equity incentives was $477 thousand and $837 thousand for the six months ended December 31, 2024, and December 31, 2023, respectively.

Stock Options

The Company’s stock option activity for the six months ended December 31, 2024, is as follows:

	Shares			Weighted Average Exercise Price
Outstanding at June 30, 2024		156,628		$	14.18
Granted		71,210			10.81
Exercised		—			—
Canceled or expired		(7,489	)		9.69
Outstanding at December 31, 2024		220,349		$	13.24

The aggregate intrinsic value was $0 for all of options exercisable and for all unvested options at December 31, 2024, because the fair value of the Company’s common stock was less than the exercise prices of these options.

The table below details the Company’s stock options outstanding as of December 31, 2024:

Range of exercise prices		Number Outstanding		Options Outstanding Weighted-Average Remaining Contractual Life (Years)		Weighted-Average Exercise Price		Number Exercisable		Options Exercisable Weighted-Average Exercise Price
$	6.99 - 19.20		217,724		8.85	$	11.57		55,778	$	13.34
$	55.50 - 84.90		418		3.86		61.52		418		61.52
$	159.00 - 175.50		2,207		2.35		168.97		2,207		168.97
$	6.99 - 175.50		220,349		8.78	$	13.24		58,403	$	19.57

Compensation costs recognized related to stock option awards were $200 thousand and $148 thousand for each of the three months ended December 31, 2024, and 2023, respectively. Compensation costs recognized related to stock option awards were $355 thousand and $204 thousand for each of the six months ended December 31, 2024, and 2023, respectively. The remaining stock-based compensation expense of $1.2 million related to stock options will be recognized over a weighted-average period of 2.13 years.

Restricted Stock

The Company’s restricted stock activity for the six months ended December 31, 2024, is as follows:

	Shares		Weighted Average Grant Date Fair Value
Outstanding at June 30, 2024	43,773		$	15.36
Granted	—			—
Vested	(6,668	)		10.10
Canceled or expired	—			—
Outstanding at December 31, 2024	37,105		$	16.30

Stock compensation expenses related to restricted stock were $61 thousand and $325 thousand for the three months ended December 31, 2024, and 2023, respectively. Stock compensation expenses related to restricted stock were $122 thousand and $633 thousand for the six months ended December 31, 2024, and 2023, respectively.  The remaining stock-based compensation expense of $429 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 2.06 years.